WHO Collaborating Centre for
Pharmaceutical Pricing and Reimbursement Policies

Activities of the WHO CC

WHO Collaborating Centres are institutions such as research institutes, parts of universities or academies, which are designated by the WHO Director-General to carry out activities in support of the Organization's programmes. For further information see the WHO’s Factsheet about Collaborating Centres.

According to the terms of reference, our WHO Collaborating Centre (WHO CC) for Pharmaceutical Pricing and Reimbursement Policies performs the following activities (see http://apps.who.int/whocc/Detail.aspx?cc_ref=AUT-14&cc_city=vienna&):

• Provides scientific advice and technical assistance to WHO and its Member States / regions on performing and interpreting price surveys and comparisons; on understanding, collecting and analyzing pharmaceutical pricing and reimbursement information and on the development of national reporting systems
• Further develops and refines the methodological framework for indicators to measure, compare and benchmark pharmaceutical policies, in coordination with the WHO database development process
• Assists in the organization of meetings of WHO Member States / regions in the field of pharmaceutical pricing and reimbursement, allowing for an exchange of information and experience, disseminates information on pharmaceutical policies (via websites, studies and network meetings) and works on the development and promotion of a common understanding and language on pharmaceutical issues

One of our activities as WHO Collaborating Centre is to provide an information platform with evidence about pharmaceutical policies. This website serves to fulfill this task. As stated in the sections PPRI and PHIS, this WHO CC website, comprising PPRI and PHIS information, will be regularly updated, while the PPRI and PHIS project websites will still be accessible, but will provide no updated information from September 2011 on.

Since WHO has been encouraging its Collaborating Centres to develop collaborative networks with other centres and national institutions recognized by WHO, we are participating in a network of Collaborating Centres working on pharmaceutical policies (more).